Literature DB >> 17692830

Localization of L-DOPA uptake and decarboxylating neuronal structures in the cat brain using dopamine immunohistochemistry.

Kunio Kitahama1, Michel Geffard, Silvia Araneda, Ryohachi Arai, Keiko Ogawa, Ikuko Nagatsu, Jean-Marc Pequignot.   

Abstract

The present study examined dopamine-immunoreactive neuronal structures using immunohistochemistry in conjunction with an anti-dopamine antiserum, following injection of l-3,4-dihydroxyphenylalanine (L-DOPA) with or without an inhibitor of monoamine oxidase (Pargyline) in the cat brain. L-DOPA injection made it possible to detect dopamine immunoreactivity in presumptive serotonergic and noradrenergic cell bodies and axons. Weak to moderate dopamine immunoreactivity was observed in non-aminergic cells (possibly so-called "D" cells containing aromatic L-amino acid decarboxylase (AADC)) in several hypothalamic, midbrain, pontine and medullary nuclei. Intense dopamine immunoreactivity became visible in a large number of cells and axons (possibly containing AADC) with wide distribution in the brain following administration of L-DOPA with Pargyline. AADC is most likely active in cells and axons that take up L-DOPA, where it decarboxylates the L-DOPA to dopamine. However, newly synthesized dopamine in such cells is rapidly oxidized by monoamine oxidase.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17692830     DOI: 10.1016/j.brainres.2007.05.081

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

Review 1.  The role of the central noradrenergic system in behavioral inhibition.

Authors:  Eric A Stone; Yan Lin; Yasmeen Sarfraz; David Quartermain
Journal:  Brain Res Rev       Date:  2011-03-05

2.  A phase I study of aromatic L-amino acid decarboxylase gene therapy for Parkinson's disease.

Authors:  Shin-ichi Muramatsu; Ken-ichi Fujimoto; Seiya Kato; Hiroaki Mizukami; Sayaka Asari; Kunihiko Ikeguchi; Tadataka Kawakami; Masashi Urabe; Akihiro Kume; Toshihiko Sato; Eiju Watanabe; Keiya Ozawa; Imaharu Nakano
Journal:  Mol Ther       Date:  2010-07-06       Impact factor: 11.454

3.  Marked behavioral activation from inhibitory stimulation of locus coeruleus alpha1-adrenoceptors by a full agonist.

Authors:  Eric A Stone; Yan Lin; Yasmeen Sarfraz; David Quartermain
Journal:  Brain Res       Date:  2009-07-24       Impact factor: 3.252

4.  Synthesis, transport, and metabolism of serotonin formed from exogenously applied 5-HTP after spinal cord injury in rats.

Authors:  Yaqing Li; Lisa Li; Marilee J Stephens; Dwight Zenner; Katherine C Murray; Ian R Winship; Romana Vavrek; Glen B Baker; Karim Fouad; David J Bennett
Journal:  J Neurophysiol       Date:  2013-09-25       Impact factor: 2.714

5.  Adjunctive therapy in Parkinson's disease: the role of rasagiline.

Authors:  Kathryn D Gaines; Vanessa K Hinson
Journal:  Neuropsychiatr Dis Treat       Date:  2012-07-02       Impact factor: 2.570

6.  A discrete dopaminergic projection from the incertohypothalamic A13 cell group to the dorsolateral periaqueductal gray in rat.

Authors:  Fany Messanvi; Ellie Eggens-Meijer; Benno Roozendaal; Johannes J van der Want
Journal:  Front Neuroanat       Date:  2013-12-06       Impact factor: 3.856

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.